ClinicaliQ Trial Snapshot
- A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma — Active Not Recruiting • Phase III • NCT05827016.
- Trial comparing iberdomide versus lenalidomide as maintenance therapy after stem cell transplant in newly diagnosed myeloma patients.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM). Conditions: Multiple Myeloma Interventions: Iberdomide, Lenalidomide Lead Sponsor: Bristol-Myers Squibb Planned Enrollment: 1230 participants